4//SEC Filing
Karas Eric 4
Accession 0001415889-24-023712
CIK 0001671858other
Filed
Sep 18, 8:00 PM ET
Accepted
Sep 19, 4:30 PM ET
Size
8.6 KB
Accession
0001415889-24-023712
Insider Transaction Report
Form 4
Karas Eric
Chief Commercial Officer
Transactions
- Exercise/Conversion
Common Stock
2024-09-18$1.50/sh+10,000$15,000→ 15,693 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-09-18−10,000→ 594,588 totalExercise: $1.50Exp: 2032-05-23→ Common Stock (10,000 underlying) - Sale
Common Stock
2024-09-18$14.00/sh−10,000$140,000→ 5,693 total
Footnotes (2)
- [F1]The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 26, 2024.
- [F2]Immediately exercisable.
Documents
Issuer
ARS Pharmaceuticals, Inc.
CIK 0001671858
Entity typeother
Related Parties
1- filerCIK 0001951287
Filing Metadata
- Form type
- 4
- Filed
- Sep 18, 8:00 PM ET
- Accepted
- Sep 19, 4:30 PM ET
- Size
- 8.6 KB